Eur Rev Med Pharmacol Sci 2023; 27 (21): 10507-10521
DOI: 10.26355/eurrev_202311_34327

Integrative multidisciplinary approaches by the Integrative Medicine Research Group (IMRG): a new frontier in cancer setting

M. Berretta, M. Montopoli, S. Cazzavillan, F. Ceppa, D. Santagà, C. Berti, D. Garozzo

Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy. berrettama@gmail.com


This conference addresses the topic of integrative, multidisciplinary approaches to cancer settings according to evidence-based medicine. The multidisciplinary approach of the researchers involved characterizes this new and complex scenario. The Integrative Medicine Research Group (IMRG) has always been committed to the activities and dissemination of CAM in cancer patients, focusing on the safety and efficacy of these approaches. Thus, one of the main goals of IMRG is to demonstrate that CAM can support cancer patients during treatment and improve their quality of life and survival. In addition, IMRG’s multidisciplinary network is ever vigilant in assessing the risks of interactions between cancer drugs and nutraceuticals. We hope that the integrative medicine approach can be transferred to the level of all chronic diseases, including oncology.

Free PDF Download

To cite this article

M. Berretta, M. Montopoli, S. Cazzavillan, F. Ceppa, D. Santagà, C. Berti, D. Garozzo
Integrative multidisciplinary approaches by the Integrative Medicine Research Group (IMRG): a new frontier in cancer setting

Eur Rev Med Pharmacol Sci
Year: 2023
Vol. 27 - N. 21
Pages: 10507-10521
DOI: 10.26355/eurrev_202311_34327